LeadCare II System
The LeadCare II system is the only CLIA-waived blood lead test, providing quantitative results in just 3 minutes from 2 drops of blood.
Magellan Biosciences
Magellan Biosciences, Inc. established their organisation in October 2004 through the combination of ESA Biosciences and Dynex Technologies – two dynamic and profitable companies that address emerging growth markets in biomedical research and clinical diagnostics. In May 2005, they acquired TekCel, which has a strong presence in pharmaceutical labs worldwide.
Browse Products by Field
Magellan Biosciences, Inc. established their organisation in October 2004 through the combination of ESA Biosciences and Dynex Technologies – two dynamic and profitable companies that address emerging growth markets in biomedical research and clinical diagnostics. In May 2005, they acquired TekCel, which has a strong presence in pharmaceutical labs worldwide.
Their analytical products range from stand-alone instruments and reagent consumables, to fully integrated systems for complex analyses and sample handling. They encompass proprietary detection technologies – including electrochemical and novel charged-aerosol detectors key to quantitative and qualitative analysis of biomolecules, microplate readers and washers for microplate-based biomolecular immunoassays, high-performance liquid chromatography (HPLC) products, and the latest in laboratory-scale automation and software. Their products also have applications in industrial R&D and academic markets.